Compared with CD19 CAR-T therapy, CD7 CAR-T therapy was characterized by reduced CD8+ CAR-T persistence, early exhaustion, and delayed immune reconstitution, correlating with increased infections and higher non-relapse mortality.
Zhi-Peng Zhou, Yi-Yang Ding, Zhuo-Jun Liu et al.· Journal of Translational Int...· 0 citations
CD19 CAR-T has achieved high remission rates in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, rapid generation with durable in vivo persistence remains a major challenge. CD45RA-negative T cells exhibit sustained antileukemic activity and preserved immune memory. Here, we developed a rapid p...
Xu-Ying Pei, Meng Lv, Xiao-Zheng Zhao et al.· Cancer Letters· 0 citations
OBJECTIVES
EBV reactivation after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is typically monitored by plasma viral load, but this fails to capture cellular reservoirs. Lineage-specific testing, though usually performed in high-risk patients, may identify biologically distinct disease states. We aim...
Zhi-Fan Zhao, Zhuo-Jun Liu, Qiang Huang et al.· Clinical Microbiology and In...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.